HKU Team Finds Way To Treat Covid With Ulcer Drug
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1554222_1_20201012174849.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-10-12 HKT 12:48
Share this story
Researchers at the University of Hong Kong said on Monday that they have found that a way to tackle the novel coronavirus with a drug that is commonly used to treat stomach ulcers.
They said experiments in the laboratory showed that the drug, ranitidine bismuth citrate (RBC), which contains a metal called bismuth, can be used to reduce viral loads in coronavirus-infected cells by over 1,000-fold.
Dr Runming Wang from the university’s Department of Chemistry said the drug is also cheaper and safer than Remdesivir, which is currently used to treat Covid-19.
He said the drug works by targeting a protein in the virus and preventing the virus from replicating.
“As the process of developing an effective vaccine is still ongoing, another approach for preventing and treatment of the disease is to identify anti-Covid-19 agents from existing drugs to repurpose their uses,” he said.
Wang said the drug can be stored at room temperature and without any special requirements.
The team said it had applied for a patent in the US.
Ant Internationals Ant Bank And Bettr Selected For Hong Kongs GenAI Sandbox++
Digital bank Ant Bank and embedded financial solutions provider Bettr have been selected to participate in Hong Kong’... Read more
Visa And BOCHK Tapped For Hong Kong AI Sandbox To Test Agent-Initiated Commerce
Visa has announced that it is partnering with Bank of China (Hong Kong) (BOCHK) in the GenA.I. Sandbox++. With the Visa... Read more
Hong Kong Regulators Pick 36 Agentic AI Use Cases For GenA.I. Sandbox++
The Hong Kong Monetary Authority (HKMA), the Securities and Futures Commission (SFC), the Insurance Authority (IA), and... Read more
Finloop And Yunfeng Financial Become Latest Anchorpoint Authorised Distributors
Finloop and Yunfeng Financial have joined Anchorpoint’s HKDAP stablecoin beta access programme as authorised distribu... Read more
Standard Chartered Becomes First Bank To Distribute HKDAP Stablecoin
Standard Chartered Bank (Hong Kong) Limited (SCBHK) has become the first bank distributor of HKDAP, the Hong Kong dolla... Read more
Lianlian DigiTech Profit Doubles In H12026, Agent Wallet Pushes To Address Payment Needs
Lianlian DigiTech Co., Ltd, a payment service provider headquartered in China, reported its interim results for the fir... Read more